PEN-FAST Penicillin Allergy Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Very low risk0–0
- Low risk1–2
- Moderate risk3–3
- High risk4–6
The PEN-FAST Penicillin Allergy Score calculates predicting invasive bacterial infection probability and quantifying systemic host response to sepsis. Key inputs include reaction within 5y. Scores guide administering empiric broad-spectrum antimicrobial regimens, infectious source control, and isolation protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Risk-stratifies reported penicillin allergy: very low risk patients may proceed to direct oral challenge.
Clinical Indication
The PEN-FAST Penicillin Allergy Score is indicated for bedside clinical practice to support Risk-stratifies reported penicillin allergy: very low risk patients may proceed to direct oral challenge.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with suspected sepsis, meningitis, pneumonia, COVID-19, opportunistic infections, or fever of unknown origin. Clinical application is indicated across Infectious disease services, septic shock bays, febrile illness clinics, and isolation units.
Limitations & Contraindications
Timely administration of empiric antibiotic therapy in suspected septic shock must never be delayed for score tabulation.
Clinical Pearls & Action Plan
Blood and site-specific microbiological cultures should be secured prior to administering broad-spectrum antimicrobials.
PEN-FAST = F(2) + A(2) + S(1) + T(1); F: allergy reported within last 5 years, A: anaphylaxis/angioedema, S: severe cutaneous adverse reaction, T: treatment required
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| reaction_within_5y | boolean | Yes | Allergy reported within the last 5 years (F) |
| anaphylaxis_angioedema | boolean | Yes | Anaphylaxis or angioedema (A) |
| severe_cutaneous_reaction | boolean | Yes | Severe cutaneous adverse reaction, e.g. SJS/TEN/DRESS (S) |
| treatment_required | boolean | Yes | Treatment required for the reaction, e.g. epinephrine or hospitalization (T) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Very low risk | Very low risk of positive penicillin allergy test |
| 1–2 | Low risk | Low risk of positive penicillin allergy test |
| 3–3 | Moderate risk | Moderate risk of positive penicillin allergy test |
| 4–6 | High risk | High risk of positive penicillin allergy test |
Evidence-Based References (EBM)
- Trubiano JA, Vogrin S, Chua KYL, et al. Development and validation of a penicillin allergy clinical decision rule. JAMA Intern Med. 2020;180(5):745-752.